when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LILLY · news · pharmadog

← back to LILLY

News mentioning LILLY

793 stories

Aug 14, 26Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myersbiopharma dive

Aug 14, 26STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticismstat

Aug 14, 26STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug classstat

Aug 14, 26Biotech initiatives pick up as more regions race to become hubsbiopharma dive

Aug 14, 26How will legal challenges fare against CMS rule on gender-affirming care?stat

Aug 14, 26Nascent US psychedelic therapy opportunity attracts overseas manufacturersbiospace

Aug 13, 26PTC takes a chance on Sangamo’s Fabry disease gene therapybiopharma dive

Aug 13, 26STAT+: Eli Lilly targets booming black market for retatrutidestat

Aug 13, 26Zealand's royalty deal; Khartis raises money for TED drugendpoints

Aug 13, 26STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and morestat

Aug 13, 26Bankrupt Sangamo offloads assets to Lilly, PTC in $161M salebiospace

Aug 13, 26PTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auctionendpoints

Aug 13, 26PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry marketfiercebiotech

Aug 12, 26Eli Lilly files first lawsuits over retatrutide 'black market'endpoints

Aug 12, 26Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pillfiercebiotech

Aug 12, 26Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutidebiopharma dive

Aug 12, 26STAT+: Cancer patients face longer wait times to begin treatment, according to new studystat

Aug 12, 26Lilly cracks down on black market for obesity asset retatrutide with six lawsuitsbiospace

Aug 12, 267 companies hiring in North Carolina nowbiospace

Aug 12, 26STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and morestat

Aug 12, 26Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlightbiospace

Aug 12, 26With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentbiospace

Aug 11, 26Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxietyfiercebiotech

Aug 11, 26Lilly paid $2B upfront for vaccine biotechs; Infinimmune raises $75Mendpoints

Aug 11, 26Amgen lays groundwork for new R&D center in Hyderabadfiercebiotech

Aug 11, 26Chasing Dupixent, a biotech aims to make better antibody drugs for eczemabiopharma dive

Aug 11, 26After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’biospace

Aug 10, 26BMS picks Texas for new $2.3B manufacturing campusbiospace

Aug 10, 26Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the massesbiopharma dive

Aug 10, 26STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and morestat

← prevpage 14 of 27next →